Insider · CIK 0001870062
Benjamin J. Zeskind
ceopresidentofficerdirectorowner
Files at IMRX (Immuneering Corp). First filing Jun 20, 2025, latest Jun 20, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$50k bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 42Moderate | Immuneering Corp | $50k 21,000 shares | +1% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 18, 2025 | IMRX Immuneering Corp | POpen-market purchase Class A Common Stock | +21,000 | $2.39 | $50k | 2,302,852 | Jun 20, 2025 |
| Feb 5, 2025 | IMRX Immuneering Corp | AGrant or award Stock Optionderivative | +480,000 | $0.00 | $0 | 480,000 | Feb 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.